Article Details
Retrieved on: 2021-04-06 13:06:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
For those who have high-risk cardiac features, novel monoclonal antibodies have started to pick up momentum. The quadruplet regimen was approved ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here